Biotechnology
Manufacturing
Health
Biogen
$229.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$229.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.59 (-0.69%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Biogen and other stocks, options, ETFs, and crypto commission-free!
About
Biogen Inc. Common Stock, also called Biogen, is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Read More It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Employees
7,800
Headquarters
Cambridge, Massachusetts
Founded
1978
Market Cap
44.46B
Price-Earnings Ratio
9.87
Dividend Yield
0.00
Average Volume
1.72M
High Today
$231.98
Low Today
$228.14
Open Price
$229.50
Volume
816.64K
52 Week High
$388.67
52 Week Low
$216.12
Collections
Biotechnology
Manufacturing
Health
Therapy
Technology
US
North America
News
Barron'sMay 16
Big Biotech Needs Big M&A to Boost Their Beaten-Down Stocks
Text size The biotech giants are hungry. Thatâs the view of JPMorgan analyst Cory Kasimov, who in a new report out Wednesday laid out the case that investors should be looking out for major acquisitions by the big biotech firms like Amgen (ticker: AMGN), Gilead (GILD), and Biogen (BIIB). âWe think itâs only a matter of time before large cap biotech pulls the trigger on meaningful transactions,â Kasimov wrote. For investors, it couldnât come a moment too soon. The stocks of Amgen, Gilead, and Biogen are ...
CNBCMay 15
Stocks making the biggest moves premarket: Alibaba, Zillow Group, Biogen, McDonald's, Beyond Meat & more
Traders work under monitors displaying 3M Co. signage on the floor of the New York Stock Exchange (NYSE) in New York. Check out the companies making headlines before the bell: Alibaba â The Chinese e-commerce giant beat estimates by a wide margin on both the top and bottom lines, driven both by increased user engagement and growth in its cloud business. Tilray â Tilray reported an adjusted quarterly loss of 27 cents per share, two cents larger than analysts were expecting. The Canadian marijuana producer...
Seeking AlphaMay 15
Britain's cost watchdog on board with Biogen's Spinraza
Britain's National Institute for Health and Care Excellence (NICE), the advisor to the National Health Service (NHS) on costs and care quality, has recommended routine access for Biogen's (NASDAQ:BIIB) SPINRAZA (nusinersen) for the treatment of infants, children and adults with 5q spinal muscular atrophy (SMA), including pre-symptomatic and symptomatic SMA Types 1, 2 and 3....
Price Paid on Robinhood
5% Lower
Right Now
52 Week Low
$216.12
Average Price Paid
$240.95
52 Week High
$388.67
Earnings
$5.26
$5.97
$6.69
$7.40
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
â
Actual
Expected Jul 23, Pre-Market